Therefore, we selected CNR2, PPARA, PTGS1 and PTGS2, four key genes that have direct or indirect effects on prognosis in NSCLC, and conducted molecular docking with β-elemene. This evidence concerns the gene PPARA and non-small cell lung carcinoma.